This meme isn’t exaggeration—it’s history repeating itself in policy.
The Schedule I drug classification was meant to indicate substances with a high potential for abuse and no accepted medical use. But as science has evolved, that definition hasn’t. Cannabis, LSD, and psilocybin still sit at the top of that list, despite mounting evidence—and actual FDA approvals—supporting their medical value. This meme visualizes the dissonance: a wall labeling them “no medical value,” undercut by headlines like “Cannabis relieves seizures” and “Psilocybin helps depression.”
The truth is, the Schedule I drug classification hasn’t kept up with medicine. Cannabis is now FDA-approved in the form of Epidiolex. Psilocybin has received breakthrough therapy designation from the FDA. LSD’s early psychiatric studies are once again being explored. Yet these substances remain legally restricted, largely out of policy inertia rather than scientific merit.
We don’t need to glorify these substances—but we do need to tell the truth. We owe patients more than outdated policy and decades-old drug war dogma. If healing is the goal, it’s time we match law to literature.
Clinical and Preclinical Study about LSD, Psilocybin, MDMA
All About Anxiety & Stress
If you like a positive stance on which forms of treatment bring benefit, and which are less healthy, and how to master them, you’ll love The Cannabis Handbook!
Here, for example, is a piece I wrote about Cough – and the healthy ways to avoid it
